FOUR GENERATIONS COMMITTED TO OVERCOMING INFECTIOUS DISEASES

 

 

 

Marcel Mérieux in is laboratory

Marcel Mérieux

1897

Marcel Mérieux, a student of Louis Pasteur, creates the Institut Biologique Mérieux.

Dr. Charles Mérieux working

Dr. Charles Mérieux

1937

Dr. Charles Mérieux succeeds his father Marcel. He launches production of the foot-and-mouth disease vaccine. This marks the birth of industrial virology.

Dr. Charles Mérieux creates IFFA

IFFA

1947

Dr. Charles Mérieux creates IFFA (Institut Français de Fièvre Aphteuse).

Alain Mérieux creates BD Mérieux

BD Mérieux

1963

Alain Mérieux creates BD Mérieux, an in vitro diagnostics company jointly owned by Institut Mérieux and Becton Dickinson.

Dr. Charles Mérieux creates Fondation Mérieux

Fondation Mérieux

1967

Dr. Charles Mérieux creates Fondation Mérieux.

Marcel, Charles and alain Mérieux

Alain Mérieux

1967

Alain Mérieux succeeds his father as the head of Institut Mérieux, which will become a world leader in the field of human and veterinary vaccines.

Institut Mérieux's Logo (1968)

Rhône-Poulenc

1968

Groupe Rhône-Poulenc acquires a stake in Institut Mérieux.

BioMérieux's poster (1974)

bioMérieux

1974

Alain Mérieux takes over BD Mérieux which becomes bioMérieux.

Mérieuscope's article (1985)

Institut Pasteur Production

1985

Institut Mérieux acquires Institut Pasteur Production (vaccines).

API Systems

API Systems

1987

bioMérieux acquires API Systems (bacterial identification).

Vitek - St Louis' office 1988

Vitek

1988

bioMérieux acquires Vitek Systems
 (bacterial identification and susceptibility testing automation) from McDonnell Douglas, a North American company.

Connaught Laboratories

Connaught Laboratories

1989

Institut Mérieux acquires Connaught Laboratories (vaccines)

Child getting vaccinated

Divestment of vaccine business

1994

The Mérieux family divests from its vaccine business (Rhône-Poulenc buys Institut Mérieux, which includes Pasteur Mérieux Sérums et Vaccins and Rhône Mérieux, now Sanofi Pasteur and Merial).

Transgene Laboratories

Transgene

1994

The Mérieux family takes control of Transgene (immunotherapy).

Stock exchange

Stock market listing

1998

Transgene is listed on the stock exchange.

Silliker Laboratories (1998)

Silliker

1998

The Mérieux family holding company takes control of Silliker Group Corporation (food safety).

Nasba box by Organon Teknika

Organon Teknika

2001

bioMérieux acquires Organon Teknika (diagnostics).

ABL Inc.'s office (2001)

ABL Inc.

2001

The Mérieux family holding company acquires ABL Inc. (CRO)

Christophe Mérieux

Fondation Rodolphe Mérieux

2001

Creation of Fondation Rodolphe Mérieux (which will become Fondation Christophe et Rodolphe Mérieux in 2006).

bioMérieux

Stock market listing

2004

bioMérieux is listed on the stock market (Euronext Paris).

Logo ADNA 2005

Personalized medicine

2005

Launch of the ADNA program on personalized medicine supported by the French government.

Institut Mérieux's logo 2009

Institut Mérieux

2009

The Mérieux Alliance holding company changes its name to Institut Mérieux to revive the historic name.

Mérieux Développement's visual (2009)

Mérieux Développement

2009

Creation of Mérieux Développement (Investment company).

Mérieux Research Grants' Logo (2009)

Mérieux Research Grants

2009

Launch of the international innovation program Mérieux Research Grants.

Mérieux NutriSciences' vusual (2010)

Mérieux NutriSciences

2010

Development of the nutrition/health unit Mérieux NutriSciences.

BioFire's visual 2014

BioFire

2014

bioMérieux acquires BioFire (syndromic diagnostics).

Alain and Alexandre Mérieux

Alexandre Mérieux

2015

Alexandre Mérieux becomes CEO of bioMérieux.